Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

LHRH antagonist

(… an-TA-guh-nist)
A substance that blocks the pituitary gland from making hormones called follicle-stimulating hormone (FSH) and luteinizing hormone (LH). In men, this causes the testicles to stop making testosterone. In women, this causes the ovaries to stop making estrogen and progesterone. Some LHRH antagonists are used to treat advanced prostate cancer. They are also used to treat certain gynecologic conditions and are being studied in the treatment of hormone-sensitive breast cancer. Also called GnRH antagonist, gonadotropin-releasing hormone antagonist, and luteinizing hormone-releasing hormone antagonist.
More Information
Search NCI's Dictionary of Cancer Terms